Mycotoxins aren’t living organisms — they’re toxic molecules that trigger antibodies capable of attaching to human tissue and setting off autoimmunity. Understanding that distinction reshapes how we test for and treat mold illness.
From “chronic Lyme” and MCAS to autism, autoimmunity, and unexplained neurological symptoms, mycotoxins are an often‑missed root cause. Drawing on decades of experience and published research, Andrew Campbell, MD, outlines the most common presentations of toxic mold exposure and why serum mycotoxin antibody testing is more reliable than urine testing.
Navigating toxin-related illnesses, particularly those involving mold exposure and mycotoxins, can feel overwhelming. However, the availability of evidence-based testing methods provides a clearer path forward. By understanding the range of laboratory assessments, clinicians can make more informed clinical decisions, differentiate between exposure and illness, and develop targeted treatment plans.
A solid supplement protocol can optimize the body’s natural detoxification processes and expedite a patient’s recovery from mycotoxin illness. Since many patients with mycotoxin illness struggle with neurological consequences, supplements that help support brain health can address common symptoms like brain fog, confusion, memory loss, sleep disruption, anxiety, depression, and mood swings. Supplements may also help repair the immune system, support the body’s cellular function and metabolic processes, and reverse oxidative cellular and tissue damage.
Toxic molds can affect the nervous system in children who are chronically exposed. Common neurological symptoms are headaches, fatigue, sleep disturbance, confusion, mood swings, nosebleeds, and cough. High levels of sensorimotor dysfunction and the related disorders in children means that toxic mold exposure should be regarded as a serious neurological health concern in children.
Why patients with chronic mold exposure can show persistent B12 deficiency despite adequate intake—and what this means for brain health.
It is an uncontested medical and scientific fact that molds and mycotoxins cause diseases in humans. Too often, they are overlooked and not part of clinicians’ differential diagnosis. Both are health hazards—molds produce metabolites such as mycotoxins and solvents, shed antigenic materials such as spores, hyphae, extracellular polysaccharides, and enzymes, which are toxic and cause immunologic responses.
Join Dr. Andrew Campbell, MD, for an evidence-based deep dive into the clinical impact of mycotoxins—secondary metabolites of toxic mold linked in the literature to neurodegenerative, autoimmune, and complex chronic conditions. In this focused webinar, Dr. Campbell will review CNS effects, blood-brain barrier penetration, demyelination, microbiome interactions, diagnostic testing strategies,Read
Mycotoxins—termed the “Great Masquerader” by the WHO—may underlie chronic inflammatory, neurologic, endocrine, and immune conditions. This clinical review outlines mechanisms, laboratory testing limitations, systemic effects, and evidence-informed treatment strategies for functional and integrative practitioners.
In this clinical protocol by Dr. Andrew Campbell, as published from our partners at Alternative Therapies in Health and Medicine, Campbell discusses the challenges to diagnosing Lyme disease and Mycotoxicosis from molds and their mycotoxins. The two frequently present in the similar manner. The following is an excerpt of hisRead
